<!DOCTYPE html>

<!--
  Created : 12/10/2011 9:59:36 AM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../XMLLightBlue.PNG'>
<a href='docs_Drugs_Midodrine.html'><img src='../../Back.PNG'></a>
<p>
QHP 2008 / Midodrine.DOCS<br>
<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; MidodrinePool &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.[Midodrine]&lt;/name&gt;<br>
&lt;topic&gt; Midodrine - Overview &lt;/topic&gt;<br>
&lt;topic&gt; Midodrine- Physical Units &lt;/topic&gt;<br>
&lt;seealso&gt; AlphaPool.MidoPart &lt;/seealso&gt;<br>
&lt;seealso&gt; AlphaBlockade.Block(%) &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.Change &lt;/name&gt;<br>
&lt;topic&gt; XXX&lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.Gain &lt;/name&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.K &lt;/name&gt;<br>
&lt;topic&gt; XXX&lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.Loss &lt;/name&gt;<br>
&lt;topic&gt; XX &lt;/topic&gt;<br>
&lt;topic&gt; XX &lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.Mass &lt;/name&gt;<br>
&lt;topic&gt; XXX&lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; MidodrinePool.VolDist &lt;/name&gt;<br>
&lt;topic&gt; VolDist - Units &lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Midodrine - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Midodrine hydrochloride forms an active metabolite, desglymidodrine<br>
that is an alpha 1-agonist, and exerts its action via activation of<br>
the alpha-adrenergic receptors of the arteriolar and venous vasculature,<br>
producing an increase in vasculature tone and elevation of blood pressure.<br>
Midodrine hydrochloride is converted to desglymidodrine in the liver<br>
and is excreted by the kidney.  <br>
Midodrine does not cross the blood-brain barrier and is therefore <br>
not associated with effects on the central nervous system. It is<br>
used in the treatment of symptomatic orthostatic hypotension. <br>
<br>
Midodrine is almost completely absorbed after oral administration<br>
with a bioavailability (as desglymidodrine) of 93%<br>
<br>
Wright RA, Kaufman HC, Perera R, Opfer-Gehrking TL, McElligott MA, <br>
Sheng KN, Low PA. A double-blind, dose-response study of midodrine<br>
in neurogenic orthostatic hypotension. Neurology 51: 120-124, 1998<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Midodrine - Physical Units &lt;/name&gt;<br>
&lt;label&gt; Physical Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Daily dosage of midodrine is reported in mG/Day <br>
Plasma levels of the active desglymidodrine are reported in nG/mL<br>
Volume of distribution is 4L/KG  <br>
<br>
Clin Pharm Ther 39:586-591, 1986<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Midodrine - Concentration Units &lt;/name&gt;<br>
&lt;label&gt; Concentration Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Typical dose is 10-30mG/Day. Midodrine is available in 2.5mG and<br>
5mG tablets for oral administration.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
   <br>
End<br>
<br>


<p><img src='../../Footer.PNG'>

</body>
</html>
